Occupational contact allergy to omeprazole and ranitidine [PDF]
Medycyna Pracy, 2017 Omeprazole is a proton pump inhibition and ranitidine is an H2 histamine receptor antagonist widely used in the treatment of gastroesophageal reflex disease, peptic ulcer disease, Zollinger-Ellison syndrome and as a protector of the gastric mucosae.
Inmaculada Herrera-Mozo +2 more
doaj +3 more sources
Association between ranitidine use and thyroid cancer based on FAERS and VigiAccess databases [PDF]
Discover OncologyPurpose The potential carcinogenic risk of ranitidine has sparked widespread controversy, and its relationship with thyroid cancer remains unclear. This study aimed to evaluate the disproportionality signal for thyroid cancer reporting associated with ...
Qingli Shen +4 more
doaj +2 more sources
Developing a Chitosan/polyvinyl alcohol hydrogel for gastro-retentive release of ranitidine and enhanced anti-ulcerative properties [PDF]
BMC BiotechnologyRanitidine is widely used to treat gastrointestinal conditions, but recent studies have revealed severe potential side effects, including a link to cancer.
Shimaa A. Sadek +13 more
doaj +2 more sources
Effects of post-hepatic portoenterostomy adjuvant therapy on liver transplantation in children with biliary atresia: A systematic review. [PDF]
JPGN RepAbstract Objectives Biliary atresia (BA) is a cholangiopathy characterized by obstruction of the intrahepatic and extrahepatic bile ducts. Hepatic portoenterostomy (HPE) is the primary palliative treatment and there is still an urgent need to improve post‐HPE management.
de Almeida Silva BF +7 more
europepmc +2 more sources
Ranitidine attenuates myocardial fibrosis by suppressing histamine/H2 receptor signaling and FAK/Src activation [PDF]
Frontiers in PharmacologyObjectiveMyocardial fibrosis (MF) is a pathological process often triggered by chronic inflammation and pressure overload. This study aimed to investigate the therapeutic potential of ranitidine, a histamine H2 receptor antagonist, on MF and explore its ...
Liwen Yang +9 more
doaj +2 more sources
Medicine and Media: The Ranitidine Debate
Clinical and Translational Science, 2020 Ranitidine has been the topic of recent media reports. Current findings, confirmed by the US Food and Drug Administration, indicate that some ranitidine products contain a substance that may be carcinogenic.
Jennifer A. Wagner, Jennifer M. Colombo
doaj +2 more sources
Ranitidine protects Müller cells against ferroptosis in diabetic retinopathy by regulating the AKT1/GSK3β pathway [PDF]
Indian Journal of OphthalmologyPurpose: This study was designed to investigate the primary targets and possible mechanisms of ranitidine (Ra) against diabetic retinopathy (DR). Methods: Single-cell sequencing technology and the SPIED3 platform were employed to characterize key genes ...
Wei He +3 more
doaj +2 more sources
Neuropsychiatric Disease and Treatment, 2015 Hongjuan Shi,1,2,* Xinxin Yang,2,3,* Hui Zhao,4 Shenyang Zhang,2 Jie Zu,2 Wei Zhang,2 Xia Shen,2 Guiyun Cui,2,3 Fang Hua,2,3 Chuanzhu Yan1 1Department of Neurology, Qilu Hospital of Shangdong University, Jinan, 2Department of Neurology, Affiliated ...
Shi H +9 more
doaj +1 more source
Pakistan Armed Forces Medical Journal, 2021 Objective: To explore the prokinetic effect of Ranitidine, to compare it with the prokinetic effect of Neostigmine and to observe the potentiating prokinetic effect of Ranitidine and Neostigmine in combination.
Aroosa Ishtiaq Butt +4 more
doaj +1 more source
Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine. [PDF]
PLoS ONE, 2017 Ranitidine (Zantac®) is a H2-receptor antagonist commonly used for the treatment of acid-related gastrointestinal diseases. Ranitidine was reported to be a substrate of the organic cation transporters OCT1 and OCT2. The hepatic transporter OCT1 is highly
Marleen Julia Meyer +3 more
doaj +1 more source